Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Subdirección Xeral de Atención Primaria.
Informe sobre a prestación farmacéutica en Galicia. Subdirección Xeral de Atención Primaria (ed).
pp. 32-35
[2.]
J. Avorn, M. Chen, R. Hartley.
Scientific versus commercial sources of influence on the prescribing behavior of physicians.
Am J Med, 73 (1982), pp. 4-8
[3.]
A.H. Anis.
Substitution laws, insurance coverage, and generic drug use.
Med Care, 32 (1994), pp. 240-256
[4.]
M.M. Chren, C.S. Landefeld, T.H. Murray.
Doctors, drug companies and gifts.
JAMA, 262 (1989), pp. 3448-3451
[5.]
W.p. McKinney, D.L. Schiedermayer, N. Lurie, D.E. Simpson, J.L. Goodman, E.C. Rich.
Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales Representatives.
JAMA, 264 (1990), pp. 1963-1967
[6.]
Furelos V. Compostela encuentra caras famosas en el aeropuerto de Barajas. El Correo Gallego. 10 Octubre 1995, 47(col. 5).
[7.]
J. Camí.
Promoción de medicamentos, promoción científica y conflicto de intereses.
Gac Sanit, 9 (1995), pp. 273-275
[8.]
J. Kangiliski.
Drug companies reach into mixed marketing bag.
Advertising Age, 265 (1985), pp. 440-442
[9.]
M.M. Chern, S. Landefeld.
Physician’ behavior and their interactions with drug companies.
JAMA, 271 (1994), pp. 684-689
[10.]
B. Hodges.
Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
Can Med Assoc, 153 (1995), pp. 553-558
[12.]
A. Mainous, W. Hueston, E. Rich.
Patient perceptions of physician acceptance of gifts from the pharmaceutical industry.
Arch Fam Med, 4 (1995), pp. 335-339
[13.]
American Medical Association Council on Ethical and Judicial Affairs.
Gifts to physicians from industry.
JAMA, 265 (1991), pp. 501
[14.]
Anónimo.
Physicians and the pharmaceutical industry.
Can Med Assoc J, 146 (1992), pp. 388A-C
[15.]
M. Reeder, J. Dougherty, L.J. White.
Pharmaceutical representatives and emergency medicine residents: a national survey.
Ann Emerg Med, 22 (1993), pp. 1593-1596
[16.]
Real Decreto 1416/1994.
del 25 de junio, por el que se regula la publicidad de los medicamentos de uso humano.
BOE del 29 de junio de, (1994),
[17.]
Physicians and the pharmaceutical industry: a position paper of the American College of Physicians.
Ann Intern Med, 112 (1990), pp. 624-626
[18.]
Ley 25/1990, de 20 de diciembre.
del Medicamento.
BOE del 22 de diciembre de, (1990),
[19.]
L.H. Margolis.
The ethics of accepting gifts from pharmaceutical companies.
Pediatrics, 88 (1991), pp. 1233-1237
[20.]
J. Gérvas, V. Ortún.
Propuesta de incentivos para una medicina general por cuenta ajena.
Gac Sanit, 10 (1996), pp. 34-39
[21.]
M. Melguizo Jiménez.
Grupo de trabajo de la SEMFYC. Incentivos en atención primaria.
Aten Primaria, 14 (1994), pp. 701-703
[22.]
J. Elola.
El gasto sanitario.
ed. Sistema Nacional de Salud: evaluación de su eficiencia y alternativas de reforma,
[23.]
P. Castillo.
Promoción y publicidad farmacéutica: Quo vadis?.
Med Clin (Bare), 99 (1992), pp. 305-309
[24.]
S.B. Soumerai, T.J. McLaurin, T.J. Avorn.
Improving drug prescribing in primary care: A critical analysis of the experimental literature.
Milbank Quarterly, 67 (1989), pp. 269-305
[25.]
D. Vinson, B. McCandless, C. Hosokawa.
Medical students’ attitudes toward pharmaceutical marketing: possibilities for change.
Educational Research and Methods, 25 (1993), pp. 31-33
[26.]
Development of residency program guidelines for interaction with the pharmaceutical industry Education Council.
Residency Training Programm in internal medicine, department of Medicine McMaster University, Hamilton. Ont.
Can Med Assoc J, 149 (1993), pp. 405-408
Copyright © 1997. Sociedad Española de Salud Pública y Administración Sanitaria
